BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioInvest

Stallergenes Greer and Nuance Pharma Enter Exclusive Partnership to Develop and Commercialise Actair® in China

Stallergenes Greer, a global leader in allergy therapeutics, and Nuance Pharma, an innovation-focused biopharmaceutical company based in China, announced t...

September 05, 2025 | News

Gilead Sciences Breaks Ground on New Foster City Technical Development Center as Part of $32B U.S. Investment

New Bay Area Building Marks Significant Progress as Part of $32 Billion U.S. Investment Projected to Create $43 Billion in Economic Value Gilead Sciences ...

September 04, 2025 | News

South Korea’s Desilo to Launch HARVEST™ Healthcare Platform in December

Desilo Inc., a privacy-technology startup specializing in cryptographic data collaboration, announced plans to launch its new healthcare platform, HAR...

September 03, 2025 | News

Thermo Fisher Expands U.S. Footprint with New $192.5M Manufacturing Center in North Carolina

Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its innovative manufacturing center of excellence ...

August 22, 2025 | News

Somite.ai Secures Strategic Investment from AMD Ventures to Advance Foundation Models for Cell Therapy

Somite.ai, a company pioneering foundation models for human stem cells, announced a strategic investment from AMD Ventures, following Somite's $...

August 21, 2025 | News

South Korea’s Avixgen, Subsidiary of Dx&Vx, Signs $360M Licensing-Out Deal with U.S. Biotech for ACP Drug Delivery Platform

This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...

August 19, 2025 | News

Philips to Invest $150M in U.S. Manufacturing and R&D to Advance AI-Enabled Ultrasound and Create Over 270 Jobs

Philips, a global leader in health technology, announced a plan for new investments of more than USD 150 million in U.S. manufacturing and research an...

August 15, 2025 | News

Fosun Pharma Licenses XH-S004 to Expedition in US$645M Deal

Fosun Pharma announced that its subsidiary Fosun Pharma Industrial has signed a License Agreement with Expedition Therapeutics Inc.(Expedition) t...

August 13, 2025 | News

Sartorius Stedim Biotech Partners with Nanotein to Advance Immune Cell Manufacturing with NanoSpark® Reagents

Nanotein’s NanoSpark® reagents enhance cell activation and expansion in cell therapy manufacturing Exclusive global distribution agreement for...

August 12, 2025 | News

Astria Licenses HAE Drug Navenibart to Japan’s Kaken in $32M+ Deal

-- Up to $32 Million in Upfront and Milestone Payments, Plus Royalties -- -- Kaken Expertise in Commercializing Innovative Therapies Supports Navenibart...

August 08, 2025 | News

XtalPi and DoveTree Medicines Forge $5.99 Billion AI-Powered Drug Discovery Alliance

XtalPi (2228.HK), a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced ...

August 07, 2025 | News

METiS Technologies Secures RMB 400 Million in Series D Funding to Advance AI-Powered Nanodelivery and Accelerate CGT Innovation

METiS Technologies, a global leader in AI-driven nanodelivery innovation, today announced the successful completion of its RMB 400 million Series...

August 05, 2025 | News

Everest Medicines Invests US$30.9 Million in I-Mab to Advance Next-Gen Immuno-Oncology Therapies

- Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash in I-Mab. Inclusive of I-MAB shares alread...

August 04, 2025 | News

Alveolus Bio Secures Strategic Investment from Shilpa Medicare to Advance Inhaled Microbiome Therapeutics

Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingh...

August 04, 2025 | News

Stay Connected